CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Kelley Shannon T General Counsel | Sale 10b5-1 | −1,077 | $400.00 | $431K | 10,397 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −60 | $533.09 | $32K | 202,907 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −106 | $534.06 | $57K | 202,801 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −218 | $535.94 | $117K | 202,583 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −160 | $537.62 | $86K | 202,423 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −687 | $540.59 | $371K | 201,736 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −368 | $541.64 | $199K | 201,368 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −1,202 | $542.60 | $652K | 200,166 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −1,539 | $544.02 | $837K | 198,627 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −761 | $544.83 | $415K | 197,866 |
| 2026-09-11 | Sibold William John President and CEO | Sale 10b5-1 | −120 | $546.38 | $66K | 197,746 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −131 | $527.88 | $69K | 209,198 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −347 | $529.27 | $184K | 208,851 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −522 | $530.23 | $277K | 208,329 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −368 | $531.99 | $196K | 207,961 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −512 | $533.09 | $273K | 207,449 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −396 | $534.20 | $212K | 207,053 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −644 | $535.27 | $345K | 206,409 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −1,040 | $536.11 | $558K | 205,369 |
| 2026-09-09 | Sibold William John President and CEO | Sale 10b5-1 | −640 | $537.17 | $344K | 204,729 |
Page 1 of 31 · 604 trades